Lincotek, a leader in the production of metal medical devices via additive manufacturing, reported it has produced over 800,000 medical devices since the company started working with Additive Manufacturing in 2006. In recent years, the count has topped over 100,000 3D printed parts per year, with best-in-class yield rates, material consumption and per-unit costs.
The group is family owned and has provided special services to global markets since 1973. It does this from its two innovation centers – one in Italy, focused on the medical sector, and the other in Switzerland, concentrating on industrial applications. In addition, the company also has AM plants and related R&D services in the US and, in the near future, in China too. In the medical field: plants are ISO 13485 certified and release implantable medical devices (CE and FDA); in IGT/Aviation: main production facilities are certified AS9100/NADCAP.
Manufacturing on Demand
By integrating the different processes that are already part of the design and development phase, Lincotek’s unique portfolio of special processes offers a complete value chain – starting from printing and going through to thermal treatments and machining, up to surface treatments and final certification. Supported materials include Titanium alloys such as CpTi and Ti6Al4V, Cobalt alloys such CoCrMo, Steel such as 17-4 SS and AISI316L, Nichel alloys such as HastX; IN625, IN718, IN738 and IN939.
Lincotek made massive investments in post-processing for serial production, supporting all the necessary steps after the 3D printing phase: from thermal treatments to machining; from coating to surface finishing; and from final cleaning to final certification.
You might also like:
* This article is reprinted from 3D Printing Media Network. If you are involved in infringement, please contact us to delete it.
Author: 3D Printing Media Network
Leave A Comment